相关实验视频
Updated: Jun 21, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
一个p53-MDM2-p21不连贯的feedforward循环的功能后果
bioRxiv : the preprint server for biology
|July 9, 2024
概括
癌细胞对治疗的反应各不相同. 研究人员发现p21表达取决于p53的变化,揭示了影响细胞循环停止和治疗耐受性的调节循环.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 分子瘤学分子瘤学
背景情况:
- 基因相同的癌细胞对治疗有异质的反应.
- 在瘤重新繁殖之前,细胞的一个亚群进入了暂时的耐治疗状态.
- 了解细胞循环阻断蛋白p21中的异质性对于癌症治疗至关重要.
研究的目的:
- 调查p21表达式中异质性的起源.
- 阐明p21的调节动态及其与p53的关系.
- 探索p21调节对治疗耐受性的作用.
主要方法:
- 活细胞光显微镜以绘制单细胞中的p21和p53动态.
- 理论和实验建模以确定p21的转录调节.
- 对p53水平和变化的p21转录速率依赖性的分析.
主要成果:
- p21转录率取决于p53的变化,而不是它的绝对水平.
- 由MDM2介导的不连贯的前循环控制了p21的转录.
- 这种网络架构促进了快速的p21诱导和转录变异性.
- 破坏前循环会导致一种静止状态,类似于治疗耐受性的持久性.
结论:
- 不连贯的p53-MDM2前循环驱动p21异质性,并影响治疗耐受性.
- 针对这种监管循环可能会提供新的治疗策略.
- 这些发现影响了针对癌症治疗中p53激活的治疗方法的开发.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

